TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Djurfarmacia Sverige AB
Closing information (x1000 NOK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
591,774
|
479,416
|
408,700 |
| Financial expenses |
2
|
36
|
275 |
| Earnings before taxes |
30,948
|
25,519
|
19,368 |
| EBITDA |
34,406
|
28,488
|
22,398 |
| Total assets |
147,509
|
122,454
|
106,428 |
| Current assets |
124,378
|
98,321
|
82,787 |
| Current liabilities |
61,093
|
50,490
|
47,815 |
| Equity capital |
81,262
|
66,834
|
54,064 |
| - share capital |
106
|
103
|
98 |
| Employees (average) |
48
|
44
|
53 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
55.1%
|
54.6%
|
50.8% |
| Turnover per employee |
12,329
|
10,896
|
7,711 |
| Profit as a percentage of turnover |
5.2%
|
5.3%
|
4.7% |
| Return on assets (ROA) |
21.0%
|
20.9%
|
18.5% |
| Current ratio |
203.6%
|
194.7%
|
173.1% |
| Return on equity (ROE) |
38.1%
|
38.2%
|
35.8% |
| Change turnover |
96,610
|
48,289
|
56,809 |
| Change turnover % |
20%
|
11%
|
16% |
| Chg. No. of employees |
4
|
-9
|
6 |
| Chg. No. of employees % |
9%
|
-17%
|
13% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.